|
ES2943510T3
(es)
*
|
2018-06-15 |
2023-06-13 |
Pfizer |
Agonistas del receptor GLP-1 y usos del mismo
|
|
ES2986417T3
(es)
|
2018-08-13 |
2024-11-11 |
Hoffmann La Roche |
Nuevos compuestos heterocíclicos como inhibidores de la monoacilglicerol lipasa
|
|
CR20210341A
(es)
|
2018-11-22 |
2021-11-25 |
Qilu Regor Therapeutics Inc |
Agonistas de glp-ir y usos de los mismos
|
|
AU2020256647B2
(en)
*
|
2019-04-12 |
2025-07-31 |
Qilu Regor Therapeutics Inc. |
GLP-1R agonists and uses thereof
|
|
US10954221B2
(en)
|
2019-04-12 |
2021-03-23 |
Qilu Regor Therapeutics Inc. |
GLP-1R agonists and uses thereof
|
|
TWI751585B
(zh)
*
|
2019-06-28 |
2022-01-01 |
美商美國禮來大藥廠 |
類升糖素肽1受體促效劑
|
|
WO2021018023A1
(zh)
*
|
2019-08-01 |
2021-02-04 |
济南泰达领创医药技术有限公司 |
小分子glp-1受体调节剂
|
|
EP4028403B1
(en)
|
2019-09-12 |
2023-11-22 |
F. Hoffmann-La Roche AG |
4,4a,5,7,8,8a-hexapyrido[4,3-b][1,4]oxazin-3-one compounds as magl inhibitors
|
|
CA3157525A1
(en)
*
|
2019-10-25 |
2021-04-29 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
JP7386997B2
(ja)
|
2019-11-15 |
2023-11-27 |
イルドン ファーマシューティカル カンパニー リミテッド |
Ｇｌｐ－１受容体アゴニストおよびその使用
|
|
WO2021154796A1
(en)
|
2020-01-29 |
2021-08-05 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
CN119841865A
(zh)
|
2020-02-07 |
2025-04-18 |
加舒布鲁姆生物公司 |
杂环glp-1激动剂
|
|
WO2021160127A1
(en)
*
|
2020-02-13 |
2021-08-19 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
TW202144340A
(zh)
*
|
2020-04-03 |
2021-12-01 |
大陸商江蘇恆瑞醫藥股份有限公司 |
稠合咪唑類衍生物、其製備方法及其在醫藥上的應用
|
|
FI4143183T3
(fi)
|
2020-04-29 |
2026-01-07 |
Gasherbrum Bio Inc |
Heterosyklisiä glp-1-agonisteja
|
|
FI4157832T3
(fi)
*
|
2020-05-27 |
2024-08-29 |
Qilu Regor Therapeutics Inc |
Glp-1r-agonistien suola- ja kidemuotoja ja niiden käyttötarkoituksia
|
|
PH12022553313A1
(en)
*
|
2020-06-04 |
2023-04-12 |
Hangzhou Sciwind Biosciences Co Ltd |
Five-membered heteroaromatic imidazole compound and use thereof
|
|
CN117645601A
(zh)
*
|
2020-06-10 |
2024-03-05 |
重庆康丁医药技术有限公司 |
一种具有心血管益处的glp-1小分子
|
|
CN113816948B
(zh)
*
|
2020-06-19 |
2023-08-11 |
江苏恒瑞医药股份有限公司 |
稠合咪唑类衍生物、其制备方法及其在医药上的应用
|
|
WO2021259309A1
(zh)
*
|
2020-06-24 |
2021-12-30 |
广州市恒诺康医药科技有限公司 |
Glp-1受体激动剂及其药物组合物和用途
|
|
PE20231181A1
(es)
|
2020-08-06 |
2023-08-11 |
Gasherbrum Bio Inc |
Agonistas del glp-1 heterociclicos
|
|
TW202214622A
(zh)
*
|
2020-08-06 |
2022-04-16 |
大陸商上海齊魯銳格醫藥研發有限公司 |
Ｇｌｐ－１ｒ促效劑及其用途
|
|
PE20231206A1
(es)
*
|
2020-08-21 |
2023-08-17 |
Terns Pharmaceuticals Inc |
Compuestos como agonistas de glp-1r
|
|
WO2022042691A1
(en)
*
|
2020-08-28 |
2022-03-03 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
AU2021306414B2
(en)
*
|
2020-09-01 |
2026-01-29 |
Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
Fused imidazole derivative, preparation method therefor, and medical use thereof
|
|
WO2022051317A1
(en)
*
|
2020-09-03 |
2022-03-10 |
Amgen Inc. |
Diol desymmetrization by nucleophilic aromatic substitution
|
|
EP4211139A4
(en)
|
2020-09-10 |
2024-12-18 |
Gasherbrum Bio, Inc. |
HETEROCYCLIC GLP-1 AGONISTS
|
|
WO2022068772A1
(zh)
*
|
2020-09-29 |
2022-04-07 |
深圳信立泰药业股份有限公司 |
一种苯并咪唑类衍生物及其制备方法和医药用途
|
|
EP4227299A4
(en)
*
|
2020-10-12 |
2025-04-09 |
Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. |
GLP-1 RECEPTOR AGONIST, BENZIMIDAZOLONE AND ITS USE
|
|
EP4229050A4
(en)
*
|
2020-10-13 |
2024-12-11 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
JP2023546054A
(ja)
*
|
2020-10-13 |
2023-11-01 |
ガシャーブラム・バイオ・インコーポレイテッド |
ヘテロ環ｇｌｐ－１アゴニスト
|
|
TWI912388B
(zh)
*
|
2020-10-14 |
2026-01-21 |
大陸商上海齊魯銳格醫藥研發有限公司 |
Ｇｌｐ-１ｒ促效劑的晶型及其用途
|
|
CN114478497B
(zh)
*
|
2020-11-12 |
2023-10-20 |
杭州中美华东制药有限公司 |
芳基烷基酸类glp-1受体激动剂及其用途
|
|
EP4247804A1
(en)
|
2020-11-20 |
2023-09-27 |
Gilead Sciences, Inc. |
Polyheterocyclic glp-1 r modulating compounds
|
|
US20240246959A1
(en)
*
|
2020-11-27 |
2024-07-25 |
Shenzhen Salubris Pharmaceuticals Co., Ltd. |
Benzimidazole derivative and preparation method therefor and medical use thereof
|
|
CN114591308B
(zh)
*
|
2020-12-03 |
2024-03-08 |
苏州闻泰医药科技有限公司 |
一类glp-1r受体激动剂化合物及其用途
|
|
WO2022135572A1
(zh)
*
|
2020-12-25 |
2022-06-30 |
四川海思科制药有限公司 |
一种五并五元环衍生物及其在医药上的应用
|
|
CA3209593A1
(en)
*
|
2021-01-28 |
2022-08-04 |
Carmot Therapeutics, Inc. |
Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their use
|
|
CN117043154A
(zh)
*
|
2021-01-28 |
2023-11-10 |
卡莫特医疗有限公司 |
Gpcr受体激动剂、包含其的药物组合物以及它们的使用方法
|
|
CN114907351A
(zh)
*
|
2021-02-07 |
2022-08-16 |
杭州中美华东制药有限公司 |
三环类glp-1受体激动剂及其用途
|
|
WO2022184849A1
(en)
|
2021-03-04 |
2022-09-09 |
Les Laboratoires Servier |
Glp-1r agonists, uses and pharmaceutical compositions thereof
|
|
EP4304711A1
(en)
*
|
2021-03-11 |
2024-01-17 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
WO2022192430A1
(en)
*
|
2021-03-11 |
2022-09-15 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
CN116940561A
(zh)
*
|
2021-03-22 |
2023-10-24 |
杭州中美华东制药有限公司 |
噻吩类glp-1受体激动剂及其用途
|
|
WO2022202864A1
(ja)
|
2021-03-24 |
2022-09-29 |
塩野義製薬株式会社 |
縮合環を有するｇｌｐ－１受容体作動薬を含有する医薬組成物
|
|
PH12023552860A1
(en)
|
2021-04-21 |
2024-05-20 |
Gilead Sciences Inc |
Carboxy-benzimidazole glp-1r modulating compounds
|
|
WO2022228490A1
(zh)
*
|
2021-04-30 |
2022-11-03 |
上海翰森生物医药科技有限公司 |
多环类衍生物调节剂、其制备方法和应用
|
|
WO2022235717A1
(en)
*
|
2021-05-03 |
2022-11-10 |
Carmot Therapeutics, Inc. |
Benzimidazoyl glp-1 receptor agonists, pharmaceutical compositions comprising the same, and methods for their use
|
|
TWI843104B
(zh)
|
2021-05-20 |
2024-05-21 |
美商美國禮來大藥廠 |
類升糖素肽1受體促效劑
|
|
WO2022268152A1
(zh)
|
2021-06-24 |
2022-12-29 |
杭州中美华东制药有限公司 |
Glp-1受体激动剂及其组合物和用途
|
|
WO2023001237A1
(en)
*
|
2021-07-21 |
2023-01-26 |
Hepagene Therapeutics (HK) Limited |
Glucagon-like peptide-1 receptor modulators and uses thereof
|
|
CN113480534B
(zh)
*
|
2021-07-23 |
2022-05-13 |
广州必贝特医药股份有限公司 |
苯并咪唑或氮杂苯并咪唑-6-羧酸类化合物及其应用
|
|
EP4382525A4
(en)
*
|
2021-08-04 |
2025-07-16 |
Shanghai Hansoh Biomedical Co Ltd |
CYCLOALKENE DERIVATIVE REGULATOR, PREPARATION METHOD AND USE THEREOF
|
|
IL310377A
(en)
*
|
2021-08-30 |
2024-03-01 |
Mindrank Ai Ltd |
Novel aryl ether substituted heterocyclic compound as glp1r agonist
|
|
WO2023038039A1
(ja)
|
2021-09-08 |
2023-03-16 |
塩野義製薬株式会社 |
抗肥満作用の関与する疾患の予防及び治療用医薬
|
|
KR20240068737A
(ko)
|
2021-09-27 |
2024-05-17 |
테른스 파마슈티칼스, 인크. |
Glp-1r 효능제로서의 벤즈이미다졸 카복실산
|
|
WO2023057414A1
(en)
|
2021-10-05 |
2023-04-13 |
Astrazeneca Ab |
Certain octahydrofuro[3,4- b]pyrazines as glp-1 receptor modulators
|
|
WO2023057429A1
(en)
|
2021-10-05 |
2023-04-13 |
Astrazeneca Ab |
Certain 2,5-diazabicyclo[4.2.0]octanes and octahydrofuro[3,4- b]pyrazines as glp-1 receptor modulators
|
|
AU2022358915A1
(en)
|
2021-10-05 |
2024-05-09 |
Astrazeneca Ab |
Certain 2,5-diazabicyclo[4.2.0]octanes as glp-1 receptor modulators
|
|
TWI843243B
(zh)
*
|
2021-10-22 |
2024-05-21 |
大陸商盛世泰科生物醫藥技術（蘇州）股份有限公司 |
作為glp-1受體激動劑的化合物、包含其的藥物組成物及其用途
|
|
AU2022375634A1
(en)
|
2021-10-25 |
2024-06-06 |
Terns Pharmaceuticals, Inc. |
Compounds as glp-1r agonists
|
|
CN115850296B
(zh)
*
|
2021-12-03 |
2025-03-11 |
杭州先为达生物科技股份有限公司 |
一种噻吩并咪唑类化合物的晶型及其制备方法
|
|
CN114163438A
(zh)
*
|
2021-12-13 |
2022-03-11 |
无锡捷化医药科技有限公司 |
一种2-甲基-3-羰基吡唑并[4,3-c]吡啶-7-羧酸盐酸盐的制备方法
|
|
US20250066338A1
(en)
|
2021-12-16 |
2025-02-27 |
Astrazeneca Ab |
Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulators
|
|
WO2023111145A1
(en)
|
2021-12-16 |
2023-06-22 |
Astrazeneca Ab |
Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulators
|
|
US20250049777A1
(en)
*
|
2021-12-23 |
2025-02-13 |
Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
Pharmaceutically acceptable salt and crystalline form of glp-1 receptor agonist and preparation method therefor
|
|
CN116354945B
(zh)
*
|
2021-12-27 |
2024-08-30 |
长春金赛药业有限责任公司 |
一种稠合咪唑羧酸类化合物及其制备方法和应用
|
|
CN118613476A
(zh)
*
|
2022-01-10 |
2024-09-06 |
西藏海思科制药有限公司 |
一种glp-1激动剂盐及其晶型及在医药上的应用
|
|
WO2023151575A1
(en)
*
|
2022-02-09 |
2023-08-17 |
Gasherbrum Bio Inc. |
Heterocyclic glp-1 agonists
|
|
KR20240150488A
(ko)
|
2022-02-23 |
2024-10-15 |
테른스 파마슈티칼스, 인크. |
Glp-1r 작용제로서의 화합물
|
|
WO2023169436A1
(zh)
|
2022-03-08 |
2023-09-14 |
广州市联瑞制药有限公司 |
苯并双环类化合物及其制备方法和应用
|
|
CN119137124A
(zh)
*
|
2022-03-09 |
2024-12-13 |
加舒布鲁姆生物公司 |
杂环glp-1激动剂
|
|
WO2023198140A1
(en)
*
|
2022-04-14 |
2023-10-19 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
US20250136584A1
(en)
*
|
2022-05-20 |
2025-05-01 |
Chengdu Di'ao Jiuhong Pharmaceutical Factory |
Benzimidazole Or Azabenzimidazole Compound, Preparation Method Therefor And Use Thereof
|
|
CN117362282B
(zh)
*
|
2022-07-07 |
2026-04-21 |
杭州德睿智药科技有限公司 |
Glp-1r激动剂的盐及其制备方法和应用
|
|
CN119923395A
(zh)
*
|
2022-07-27 |
2025-05-02 |
卡莫特医疗有限公司 |
N-杂环gpcr受体激动剂、包含其的药物组合物和其使用方法
|
|
IL319453A
(en)
*
|
2022-09-06 |
2025-05-01 |
Mindrank Therapeutics Suzhou New Drug Res And Development Co Ltd |
Polymorph of a GLP-1R agonist compound, method of preparation thereof and use thereof
|
|
US20260097037A1
(en)
|
2022-09-22 |
2026-04-09 |
Shionogi & Co., Ltd. |
Fused ring compound having glp-1 receptor agonist effect
|
|
CN116102543B
(zh)
*
|
2022-10-21 |
2025-07-22 |
江南大学 |
一种glp-1r激动剂、合成方法及其用途
|
|
WO2024102625A1
(en)
|
2022-11-11 |
2024-05-16 |
Eli Lilly And Company |
Glucagon-like peptide 1 receptor agonists
|
|
IL320810A
(en)
|
2022-11-16 |
2025-07-01 |
Lilly Co Eli |
Glucagon-like peptide 1 receptor agonists
|
|
CN120530106A
(zh)
*
|
2022-12-13 |
2025-08-22 |
杭州中美华东制药有限公司 |
Glp-1受体激动剂的新晶型和制备方法及其药物组合物和用途
|
|
TW202440556A
(zh)
*
|
2022-12-13 |
2024-10-16 |
中國大陸商杭州中美華東製藥有限公司 |
鹽型的glp-1受體激動劑、其晶型和製備方法及其藥物組合物和用途
|
|
EP4652167A1
(en)
*
|
2023-01-17 |
2025-11-26 |
Fochon Biosciences, Ltd. |
Glp-1r agonists and uses thereof
|
|
EP4660194A1
(en)
*
|
2023-02-02 |
2025-12-10 |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. |
Salt and crystal form of cycloalkene compound, and preparation method therefor and use thereof
|
|
AU2024222719A1
(en)
|
2023-02-16 |
2025-08-21 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
US20240398794A1
(en)
|
2023-04-07 |
2024-12-05 |
Terns Pharmaceuticals, Inc. |
COMBINATIONS OF GLP-1R AND THRß AGONISTS AND METHODS OF USE THEREOF
|
|
WO2024212742A1
(zh)
*
|
2023-04-10 |
2024-10-17 |
上海研健新药研发有限公司 |
一种glp-1r激动剂，其制备方法和应用
|
|
TW202504600A
(zh)
*
|
2023-07-04 |
2025-02-01 |
大陸商杭州中美華東製藥有限公司 |
Glp1r激動劑及其中間體的製備方法
|
|
TW202521533A
(zh)
|
2023-09-14 |
2025-06-01 |
香港商歌禮製藥(中國)有限公司 |
Glp-1r 激動劑及其治療方法
|
|
US12291530B1
(en)
|
2023-11-24 |
2025-05-06 |
Ascletis Pharma (China) Co., Limited |
GLP-1R agonist and therapeutic method thereof
|
|
WO2025158275A1
(en)
|
2024-01-24 |
2025-07-31 |
Pfizer Inc. |
Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compounds
|
|
WO2025189141A1
(en)
|
2024-03-08 |
2025-09-12 |
Annapurna Bio, Inc. |
Methods for treating obesity and increasing weight loss
|
|
WO2026059341A1
(ko)
*
|
2024-09-11 |
2026-03-19 |
한미약품 주식회사 |
Glp-1 수용체 작용제 및 이의 용도
|